Bonharen IVN, 10mg/ml, Solution for injection
Bonharen IVN, 10mg/ml, Solution for injection
Authorised
- SODIUM HYALURONATE
Product identification
Medicine name:
Bonharen IVN, 10mg/ml, Solution for injection
Bonharen IVN, 10mg/ml, Injekční roztok
Active substance:
- SODIUM HYALURONATE
Target species:
-
Horse
-
Dog
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
SODIUM HYALURONATE10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
- Horse
-
Milk0hour
-
Meat and offal0day
-
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM09AX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Package description:
- Glass Vial 5 x 6.0 millilitre(s)
- Glass Vial 6 x 6.0 millilitre(s)
- Glass Vial 3 x 6.0 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Contipro a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Contipro a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 96/040/18-C
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0163/001
Concerned member states:
-
Austria
-
Belgium
-
Hungary
-
Ireland
-
Slovakia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 24/05/2022
Czech (PDF)
Published on: 24/05/2022
eu-puar-czv0163001-mr-bonharen_ivn-en.pdf
English (PDF)
Download Published on: 16/11/2023
How useful was this page?:
